← Open Payments lookup

KARLA CALZADA MORALES: Open Payments

NPI 1013368349 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$699 in 32 payments from 10 companies in 2025. Trend: 2023 $50 · 2024 $747 · 2025 $699

Food & beverage: $699
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.8$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$120
Alkermes, Inc.4$81
Neurocrine BioSciences, Inc.3$75
Teva Pharmaceuticals USA, Inc.3$58
Janssen Pharmaceuticals, Inc2$56
Otsuka America Pharmaceutical, Inc.3$52
Luye Pharma (USA) Ltd.2$47
ABBVIE INC.2$43
Vanda Pharmaceuticals Inc.1$17

Products named: COBENFY, CAPLYTA, INGREZZA, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE, VRAYLAR.

Industry payments across FL — which companies pay providers there.